Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
20.8%
% of CANC's 48 holdings also in SBIO
11.8%
% of SBIO's 90 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.0% | 2.9% | 2.9% |
 |
MERUS N.V. | 3.2% | 2.9% | 2.9% |
 |
IDEAYA BIOSCIENCES, INC. | 1.8% | 1.4% | 1.4% |
|
CG ONCOLOGY, INC. | 1.0% | 1.5% | 1.0% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 0.7% | 1.3% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 5.7% |
|
ELI LILLY & CO | 5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.1% |
|
BRIDGEBIO PHARMA, INC. | 4.5% |
|
NOVARTIS AG | 4.3% |
|
ASTRAZENECA PLC | 4.2% |
|
BRISTOL-MYERS SQUIBB CO | 4.0% |
|
NUVALENT, INC. CLASS A | 3.9% |
|
SUMMIT THERAPEUTICS INC | 3.9% |
|
EXELIXIS INC | 3.8% |
CANC Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -4.4% |
 |
ALKERMES PLC | -4.1% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.8% |
|
PTC THERAPEUTICS INC | -3.6% |
|
AVIDITY BIOSCIENCES INC | -3.1% |
|
AKERO THERAPEUTICS, INC. | -2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.8% |
|
CRINETICS PHARMACEUTICALS INC | -2.7% |
|
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.3% |